223 related articles for article (PubMed ID: 11669582)
1. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo.
Cai L; Yin JP; Starovasnik MA; Hogue DA; Hillan KJ; Mort JS; Filvaroff EH
Cytokine; 2001 Oct; 16(1):10-21. PubMed ID: 11669582
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown.
Cai L; Suboc P; Hogue DA; Fei DT; Filvaroff EH
J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737
[TBL] [Abstract][Full Text] [Related]
3. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB
Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis.
Pacquelet S; Presle N; Boileau C; Dumond H; Netter P; Martel-Pelletier J; Pelletier JP; Terlain B; Jouzeau JY
J Rheumatol; 2002 Dec; 29(12):2602-10. PubMed ID: 12465160
[TBL] [Abstract][Full Text] [Related]
6. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
7. Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1.
Majumdar MK; Chockalingam PS; Bhat RA; Sheldon R; Keohan C; Blanchet T; Glasson S; Morris EA
J Cell Physiol; 2008 Apr; 215(1):68-76. PubMed ID: 17960567
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis.
Van de Loo FA; Arntz OJ; Van den Berg WB
Cytokine; 1997 Jul; 9(7):453-62. PubMed ID: 9237807
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
10. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
Wang J; Elewaut D; Veys EM; Verbruggen G
Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
[TBL] [Abstract][Full Text] [Related]
12. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
[TBL] [Abstract][Full Text] [Related]
14. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases.
Häuselmann HJ; Stefanovic-Racic M; Michel BA; Evans CH
J Immunol; 1998 Feb; 160(3):1444-8. PubMed ID: 9570565
[TBL] [Abstract][Full Text] [Related]
15. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
[TBL] [Abstract][Full Text] [Related]
17. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
19. Human knee and ankle cartilage explants: catabolic differences.
Eger W; Schumacher BL; Mollenhauer J; Kuettner KE; Cole AA
J Orthop Res; 2002 May; 20(3):526-34. PubMed ID: 12038627
[TBL] [Abstract][Full Text] [Related]
20. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
